Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Nature (2019) Vol. 575, Iss. 7782, pp. 299-309
Open Access | Times Cited: 2038

Showing 1-25 of 2038 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1599
Metal–Organic Frameworks for Biomedical Applications
Jie Yang, Ying‐Wei Yang
Small (2020) Vol. 16, Iss. 10
Closed Access | Times Cited: 785
Unlocking the potential of antibody–drug conjugates for cancer therapy
Joshua Z. Drago, Shanu Modi, Sarat Chandarlapaty
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 6, pp. 327-344
Open Access | Times Cited: 766
Targeting metastatic cancer
Karuna Ganesh, Joan Massagué
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 34-44
Open Access | Times Cited: 734
Toward personalized treatment approaches for non-small-cell lung cancer
Meina Wang, Roy S. Herbst, Chris Boshoff
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1345-1356
Closed Access | Times Cited: 693
Overcoming Endocrine Resistance in Breast Cancer
Ariella B. Hanker, Dhivya R. Sudhan, Carlos L. Arteaga
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 496-513
Open Access | Times Cited: 647
Targeting drugs to tumours using cell membrane-coated nanoparticles
Ronnie H. Fang, Weiwei Gao, Liangfang Zhang
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 33-48
Closed Access | Times Cited: 469
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu, Miaofeng Zhang, Faying Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 411
NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 394
Mitochondrial dynamics in health and disease: mechanisms and potential targets
Wen Chen, Huakan Zhao, Yongsheng Li
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 375
SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
Shuyu Zheng, Wenyu Wang, Jehad Aldahdooh, et al.
Genomics Proteomics & Bioinformatics (2022) Vol. 20, Iss. 3, pp. 587-596
Open Access | Times Cited: 355
Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 354
Overcoming therapy resistance in EGFR-mutant lung cancer
Antonio Passaro, Pasi A. Jänne, Tony Mok, et al.
Nature Cancer (2021) Vol. 2, Iss. 4, pp. 377-391
Closed Access | Times Cited: 347
Challenges and Opportunities in Cancer Drug Resistance
Richard A. Ward, Stephen E. Fawell, Nicolas Floc’h, et al.
Chemical Reviews (2020) Vol. 121, Iss. 6, pp. 3297-3351
Closed Access | Times Cited: 327
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Cristina Dehelean, Iasmina Marcovici, Codruța Şoica, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1109-1109
Open Access | Times Cited: 305
TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment
Ya Han, Yuting Wang, Xin Dong, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1425-D1431
Open Access | Times Cited: 267
Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO 3 nanoformulation triggers ferroptosis in target tumor cells
Chencheng Xue, Menghuan Li, Yang Zhao, et al.
Science Advances (2020) Vol. 6, Iss. 18
Open Access | Times Cited: 259
Chalcone Derivatives: Role in Anticancer Therapy
Yang Ouyang, Juanjuan Li, Xinyue Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 249
Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 248
Metastasis-Initiating Cells and Ecosystems
Joan Massagué, Karuna Ganesh
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 971-994
Open Access | Times Cited: 245
Sarcoma treatment in the era of molecular medicine
Thomas G. P. Grünewald, Marta M. Alonso, Sofia Avnet, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 11
Open Access | Times Cited: 241
Untapped Potentials of Endophytic Fungi: A Review of Novel Bioactive Compounds with Biological Applications
Madira Coutlyne Manganyi, Collins Njie Ateba
Microorganisms (2020) Vol. 8, Iss. 12, pp. 1934-1934
Open Access | Times Cited: 199
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy
Masoud Delfi, Rossella Sartorius, Milad Ashrafizadeh, et al.
Nano Today (2021) Vol. 38, pp. 101119-101119
Open Access | Times Cited: 195
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 192
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
Antonio Passaro, Julie R. Brahmer, Scott Antonia, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 598-610
Closed Access | Times Cited: 184
Page 1 - Next Page

Scroll to top